Rubella Virus gpE1 Antibody (5D11): sc-101364

Rubella Virus gpE1 Antibody (5D11) is a mouse monoclonal IgG1 antibody that detects the E1 glycoprotein of Rubella Virus origin by western blotting (WB), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Rubella Virus gpE1 (5D11) antibody is available in a non-conjugated form, specifically designed for researchers studying the Rubella Virus, which is responsible for the disease known as Rubella, or German measles. This virus is primarily transmitted through respiratory droplets, and its symptoms can be so mild that they often go unnoticed, complicating diagnosis and control efforts. The E1 glycoprotein plays a crucial role in the virus′s ability to infect host cells, as E1 is involved in the fusion of the viral envelope with the host cell membrane, a critical step for viral entry and subsequent replication. Understanding the structure and function of E1 is vital for developing effective vaccines and therapeutic strategies against Rubella Virus. E1 exists in various forms, including disulfide-bonded dimers and heterodimers, which are essential for functionality and interaction with host cell receptors. The presence of specific epitopes within E1, such as those responsible for hemagglutination and virus neutralization, further underscores E1′s importance in the immune response to Rubella Virus.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Rubella Virus gpE1 Antibody (5D11) References:

1. Characterization of the zinc binding activity of the rubella virus nonstructural protease.  |  Liu, X., et al. 2000. J Virol. 74: 5949-56. PMID: 10846076
2. Mutations in the E1 hydrophobic domain of rubella virus impair virus infectivity but not virus assembly.  |  Qiu, Z., et al. 2000. J Virol. 74: 6637-42. PMID: 10864678
3. Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.  |  Cordoba, P., et al. 2000. Clin Diagn Lab Immunol. 7: 964-6. PMID: 11063507
4. Structural maturation of rubella virus in the Golgi complex.  |  Risco, C., et al. 2003. Virology. 312: 261-9. PMID: 12919732
5. Phylogenetic analysis of envelope glycoprotein (E1) gene of rubella viruses prevalent in Japan in 2004.  |  Saitoh, M., et al. 2006. Microbiol Immunol. 50: 179-85. PMID: 16547415
6. Analyses of phosphorylation events in the rubella virus capsid protein: role in early replication events.  |  Law, LJ., et al. 2006. J Virol. 80: 6917-25. PMID: 16809297
7. Effects of disulfide bridges glycoprotein E1 on fusogenic activity of Rubella virus.  |  Liu, XL., et al. 2009. Acta Virol. 53: 29-34. PMID: 19301948
8. Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome.  |  Hyde, TB., et al. 2015. J Infect Dis. 212: 57-66. PMID: 25362195
9. First report of the genomic characterization of rubella viruses circulating in Cameroon.  |  Obam Mekanda, FM., et al. 2019. J Med Virol. 91: 928-934. PMID: 30822356
10. A model of the structural organization of rubella virions.  |  Waxham, MN. and Wolinsky, JS. 1985. Rev Infect Dis. 7 Suppl 1: S133-9. PMID: 4001720
11. Identification of the rubella virus nonstructural proteins.  |  Forng, RY. and Frey, TK. 1995. Virology. 206: 843-53. PMID: 7856097
12. Sequence variation in 5' termini of rubella virus genomes: changes affecting structure of the 5' proximal stem-loop.  |  Johnstone, P., et al. 1996. Arch Virol. 141: 2471-7. PMID: 9526551